Guardian Pharmacy Services Inc (NYSE:GRDN)

Q2 2026 Guardian Pharmacy Services Inc Earnings Call Transcript

Aug 6, 2026 / 08:30 PM GMT

Release Date Price: $39.47 (-2.54%)

Transcript 10-Q8-K

Key Points

Positve

Guardian Pharmacy Services Inc (GRDN) raised its full-year 2026 revenue and adjusted EBITDA guidance, reflecting strong first-half performance and confidence in the business outlook.
Adjusted EBITDA grew 23% in the first half of 2026, demonstrating successful mitigation of the profitability impact from IRA-related pricing reductions.
Residents served and script volumes both increased high single-digits year-over-year, indicating continued organic growth and strong demand.
Gross profit increased 18% year-over-year in Q2, with gross margin expanding to 22.8%, driven by favorable product and payer mix and operational efficiencies.
The company is actively expanding through strategic M&A and greenfield startups, including the acquisition of Wellness Concepts and a new pharmacy in Lexington, Kentucky.
Guardian Pharmacy Services Inc (GRDN) maintains a strong balance sheet with nearly $90 million in cash and no debt, providing significant financial flexibility for future growth initiatives.

Negative

Reported revenue growth was only 2% in Q2 due to the negative impact of IRA-related pricing reductions, masking the underlying low double-digit growth.
Reported revenue in the second half of 2026 is expected to decline by a low single-digit percentage year-over-year due to continued IRA pricing pressures.
The company faces ongoing uncertainty and potential revenue impact from the next tranche of IRA pricing changes expected in 2027 and 2028.
Recent acquisitions and greenfield startups continue to dilute consolidated margins, though the impact is gradually decreasing.
The company is maintaining a 'standstill mode' regarding potential Omnicare asset opportunities, creating uncertainty around capital deployment and future growth prospects.
Higher fuel costs continue to pressure gross profit, adding to operational headwinds.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

GRDN.N - Guardian Pharmacy Services, Inc.
Q2 2026 Guardian Pharmacy Services Inc Earnings Call
Aug 06, 2026 / 08:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
To their most directly comparable GAAP financial measures in today's press release, which again is available on our Investor Relations website.

And now I will turn it over to Fred for high-level commentary.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, Ashley, and good afternoon, everyone.

We appreciate you joining us today to review Guardian's second quarter results.

But before David and Will review the second quarter in detail.

I would like to begin with some perspective on our performance through the first

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

7-Day Free Trial · Cancel Anytime

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.